AXSM
Axsome Therapeutics, Inc.
NASDAQ · USHealthcareBiotechnology
$221.64-3.63%
Price as of Jul 20, 2026
AXSM profitability
Axsome Therapeutics, Inc. profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 92.6%
- EBITDA margin
- -24.4%
- EBIT margin
- -24.8%
- Net margin
- -26.6%
- Free cash flow margin
- -10.0%
Returns
- Return on equity
- -345.0%
- Return on assets
- -26.4%
- Return on invested capital
- -64.0%
- Asset turnover
- 1.01x
Cash efficiency
- Cash from operations
- -$70.7M
- Cash per share
- $5.93
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.